AM 720 KDWN
News, Traffic, Weather

How the Dow Jones industrial average did Thursday

KDWN

Biotech and Internet stocks tumbled again Thursday, and the broader market followed. After a two-day respite, investors again dumped shares of cutting-edge drug companies and other industries that have soared over the past year as they worried those stocks had become too expensive. The Nasdaq composite fell 3 percent, its worst drop since November 2011. Gilead Sciences was among the big biotech names to take a beating, giving up 7 percent. The stock doubled in value last year. Facebook, which also doubled last year, sank 5 percent.

On Wednesday:

The Dow Jones industrial average fell 266.96 points, or 1.6 percent, to 16,170.22.

The Standard & Poor’s 500 index fell 39.10 points, or 2.1 percent, to 1,833.08.

The Nasdaq composite fell 129.79 points, or 3.1 percent, to 4,054.11.

For the week:

The Dow Jones industrial average is down 242.49 points, or 1.5 percent.

The Standard & Poor’s 500 index is down 32.01 points, or 1.7 percent.

The Nasdaq composite is down 73.62 points, or 1.8 percent.

For the year:

The Dow Jones industrial average is down 406.44 points, or 2.5 percent.

The Standard & Poor’s 500 index is down 15.28 points, or 0.8 percent.

The Nasdaq composite is down 122.48 points, or 2.9 percent.

How the Dow Jones industrial average did Thursday

KDWN

Biotech and Internet stocks tumbled again Thursday, and the broader market followed. After a two-day respite, investors again dumped shares of cutting-edge drug companies and other industries that have soared over the past year as they worried those stocks had become too expensive. The Nasdaq composite fell 3 percent, its worst drop since November 2011. Gilead Sciences was among the big biotech names to take a beating, giving up 7 percent. The stock doubled in value last year. Facebook, which also doubled last year, sank 5 percent.

On Wednesday:

The Dow Jones industrial average fell 266.96 points, or 1.6 percent, to 16,170.22.

The Standard & Poor’s 500 index fell 39.10 points, or 2.1 percent, to 1,833.08.

The Nasdaq composite fell 129.79 points, or 3.1 percent, to 4,054.11.

For the week:

The Dow Jones industrial average is down 242.49 points, or 1.5 percent.

The Standard & Poor’s 500 index is down 32.01 points, or 1.7 percent.

The Nasdaq composite is down 73.62 points, or 1.8 percent.

For the year:

The Dow Jones industrial average is down 406.44 points, or 2.5 percent.

The Standard & Poor’s 500 index is down 15.28 points, or 0.8 percent.

The Nasdaq composite is down 122.48 points, or 2.9 percent.

How the Dow Jones industrial average did Thursday

KDWN

Biotech and Internet stocks tumbled again Thursday, and the broader market followed. After a two-day respite, investors again dumped shares of cutting-edge drug companies and other industries that have soared over the past year as they worried those stocks had become too expensive. The Nasdaq composite fell 3 percent, its worst drop since November 2011. Gilead Sciences was among the big biotech names to take a beating, giving up 7 percent. The stock doubled in value last year. Facebook, which also doubled last year, sank 5 percent.

On Wednesday:

The Dow Jones industrial average fell 266.96 points, or 1.6 percent, to 16,170.22.

The Standard & Poor’s 500 index fell 39.10 points, or 2.1 percent, to 1,833.08.

The Nasdaq composite fell 129.79 points, or 3.1 percent, to 4,054.11.

For the week:

The Dow Jones industrial average is down 242.49 points, or 1.5 percent.

The Standard & Poor’s 500 index is down 32.01 points, or 1.7 percent.

The Nasdaq composite is down 73.62 points, or 1.8 percent.

For the year:

The Dow Jones industrial average is down 406.44 points, or 2.5 percent.

The Standard & Poor’s 500 index is down 15.28 points, or 0.8 percent.

The Nasdaq composite is down 122.48 points, or 2.9 percent.

How the Dow Jones industrial average did Thursday

KDWN

Biotech and Internet stocks tumbled again Thursday, and the broader market followed. After a two-day respite, investors again dumped shares of cutting-edge drug companies and other industries that have soared over the past year as they worried those stocks had become too expensive. The Nasdaq composite fell 3 percent, its worst drop since November 2011. Gilead Sciences was among the big biotech names to take a beating, giving up 7 percent. The stock doubled in value last year. Facebook, which also doubled last year, sank 5 percent.

On Wednesday:

The Dow Jones industrial average fell 266.96 points, or 1.6 percent, to 16,170.22.

The Standard & Poor’s 500 index fell 39.10 points, or 2.1 percent, to 1,833.08.

The Nasdaq composite fell 129.79 points, or 3.1 percent, to 4,054.11.

For the week:

The Dow Jones industrial average is down 242.49 points, or 1.5 percent.

The Standard & Poor’s 500 index is down 32.01 points, or 1.7 percent.

The Nasdaq composite is down 73.62 points, or 1.8 percent.

For the year:

The Dow Jones industrial average is down 406.44 points, or 2.5 percent.

The Standard & Poor’s 500 index is down 15.28 points, or 0.8 percent.

The Nasdaq composite is down 122.48 points, or 2.9 percent.

How the Dow Jones industrial average did Thursday

KDWN

Biotech and Internet stocks tumbled again Thursday, and the broader market followed. After a two-day respite, investors again dumped shares of cutting-edge drug companies and other industries that have soared over the past year as they worried those stocks had become too expensive. The Nasdaq composite fell 3 percent, its worst drop since November 2011. Gilead Sciences was among the big biotech names to take a beating, giving up 7 percent. The stock doubled in value last year. Facebook, which also doubled last year, sank 5 percent.

On Wednesday:

The Dow Jones industrial average fell 266.96 points, or 1.6 percent, to 16,170.22.

The Standard & Poor’s 500 index fell 39.10 points, or 2.1 percent, to 1,833.08.

The Nasdaq composite fell 129.79 points, or 3.1 percent, to 4,054.11.

For the week:

The Dow Jones industrial average is down 242.49 points, or 1.5 percent.

The Standard & Poor’s 500 index is down 32.01 points, or 1.7 percent.

The Nasdaq composite is down 73.62 points, or 1.8 percent.

For the year:

The Dow Jones industrial average is down 406.44 points, or 2.5 percent.

The Standard & Poor’s 500 index is down 15.28 points, or 0.8 percent.

The Nasdaq composite is down 122.48 points, or 2.9 percent.

How the Dow Jones industrial average did Thursday

KDWN

Biotech and Internet stocks tumbled again Thursday, and the broader market followed. After a two-day respite, investors again dumped shares of cutting-edge drug companies and other industries that have soared over the past year as they worried those stocks had become too expensive. The Nasdaq composite fell 3 percent, its worst drop since November 2011. Gilead Sciences was among the big biotech names to take a beating, giving up 7 percent. The stock doubled in value last year. Facebook, which also doubled last year, sank 5 percent.

On Wednesday:

The Dow Jones industrial average fell 266.96 points, or 1.6 percent, to 16,170.22.

The Standard & Poor’s 500 index fell 39.10 points, or 2.1 percent, to 1,833.08.

The Nasdaq composite fell 129.79 points, or 3.1 percent, to 4,054.11.

For the week:

The Dow Jones industrial average is down 242.49 points, or 1.5 percent.

The Standard & Poor’s 500 index is down 32.01 points, or 1.7 percent.

The Nasdaq composite is down 73.62 points, or 1.8 percent.

For the year:

The Dow Jones industrial average is down 406.44 points, or 2.5 percent.

The Standard & Poor’s 500 index is down 15.28 points, or 0.8 percent.

The Nasdaq composite is down 122.48 points, or 2.9 percent.

How the Dow Jones industrial average did Thursday

KDWN

Biotech and Internet stocks tumbled again Thursday, and the broader market followed. After a two-day respite, investors again dumped shares of cutting-edge drug companies and other industries that have soared over the past year as they worried those stocks had become too expensive. The Nasdaq composite fell 3 percent, its worst drop since November 2011. Gilead Sciences was among the big biotech names to take a beating, giving up 7 percent. The stock doubled in value last year. Facebook, which also doubled last year, sank 5 percent.

On Wednesday:

The Dow Jones industrial average fell 266.96 points, or 1.6 percent, to 16,170.22.

The Standard & Poor’s 500 index fell 39.10 points, or 2.1 percent, to 1,833.08.

The Nasdaq composite fell 129.79 points, or 3.1 percent, to 4,054.11.

For the week:

The Dow Jones industrial average is down 242.49 points, or 1.5 percent.

The Standard & Poor’s 500 index is down 32.01 points, or 1.7 percent.

The Nasdaq composite is down 73.62 points, or 1.8 percent.

For the year:

The Dow Jones industrial average is down 406.44 points, or 2.5 percent.

The Standard & Poor’s 500 index is down 15.28 points, or 0.8 percent.

The Nasdaq composite is down 122.48 points, or 2.9 percent.

How the Dow Jones industrial average did Thursday

KDWN

Biotech and Internet stocks tumbled again Thursday, and the broader market followed. After a two-day respite, investors again dumped shares of cutting-edge drug companies and other industries that have soared over the past year as they worried those stocks had become too expensive. The Nasdaq composite fell 3 percent, its worst drop since November 2011. Gilead Sciences was among the big biotech names to take a beating, giving up 7 percent. The stock doubled in value last year. Facebook, which also doubled last year, sank 5 percent.

On Wednesday:

The Dow Jones industrial average fell 266.96 points, or 1.6 percent, to 16,170.22.

The Standard & Poor’s 500 index fell 39.10 points, or 2.1 percent, to 1,833.08.

The Nasdaq composite fell 129.79 points, or 3.1 percent, to 4,054.11.

For the week:

The Dow Jones industrial average is down 242.49 points, or 1.5 percent.

The Standard & Poor’s 500 index is down 32.01 points, or 1.7 percent.

The Nasdaq composite is down 73.62 points, or 1.8 percent.

For the year:

The Dow Jones industrial average is down 406.44 points, or 2.5 percent.

The Standard & Poor’s 500 index is down 15.28 points, or 0.8 percent.

The Nasdaq composite is down 122.48 points, or 2.9 percent.

How the Dow Jones industrial average did Thursday

KDWN

Biotech and Internet stocks tumbled again Thursday, and the broader market followed. After a two-day respite, investors again dumped shares of cutting-edge drug companies and other industries that have soared over the past year as they worried those stocks had become too expensive. The Nasdaq composite fell 3 percent, its worst drop since November 2011. Gilead Sciences was among the big biotech names to take a beating, giving up 7 percent. The stock doubled in value last year. Facebook, which also doubled last year, sank 5 percent.

On Wednesday:

The Dow Jones industrial average fell 266.96 points, or 1.6 percent, to 16,170.22.

The Standard & Poor’s 500 index fell 39.10 points, or 2.1 percent, to 1,833.08.

The Nasdaq composite fell 129.79 points, or 3.1 percent, to 4,054.11.

For the week:

The Dow Jones industrial average is down 242.49 points, or 1.5 percent.

The Standard & Poor’s 500 index is down 32.01 points, or 1.7 percent.

The Nasdaq composite is down 73.62 points, or 1.8 percent.

For the year:

The Dow Jones industrial average is down 406.44 points, or 2.5 percent.

The Standard & Poor’s 500 index is down 15.28 points, or 0.8 percent.

The Nasdaq composite is down 122.48 points, or 2.9 percent.